about
Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications.Identification of urinary peptide biomarkers associated with rheumatoid arthritis.Improving peptide relative quantification in MALDI-TOF MS for biomarker assessment.Acute kidney injury prediction in cardiac surgery patients by a urinary peptide pattern: a case-control validation study.Recent advances in capillary electrophoresis coupled to mass spectrometry for clinical proteomic applications.Dark chocolate consumption improves leukocyte adhesion factors and vascular function in overweight men.Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study.Bioavailability of chlorogenic acids following acute ingestion of coffee by humans with an ileostomy.Green tea flavan-3-ols: colonic degradation and urinary excretion of catabolites by humans.In vitro and in vivo conjugation of dietary hydroxycinnamic acids by UDP-glucuronosyltransferases and sulfotransferases in humans.Absorption, metabolism, and excretion of green tea flavan-3-ols in humans with an ileostomy.In vitro studies on the stability in the proximal gastrointestinal tract and bioaccessibility in Caco-2 cells of chlorogenic acids from spent coffee grounds.Bioavailability of C-linked dihydrochalcone and flavanone glucosides in humans following ingestion of unfermented and fermented rooibos teas.Metabolite profiling of hydroxycinnamate derivatives in plasma and urine after the ingestion of coffee by humans: identification of biomarkers of coffee consumption.Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans.Absorption, disposition, metabolism, and excretion of [3-(14)C]caffeic acid in rats.Methods in capillary electrophoresis coupled to mass spectrometry for the identification of clinical proteomic/peptidomic biomarkers in biofluids.Impact of dose on the bioavailability of coffee chlorogenic acids in humansUrinary proteomic biomarkers to predict cardiovascular eventsGastrointestinal stability and bioavailability of (poly)phenolic compounds following ingestion of Concord grape juice by humansFetal Urinary Peptides to Predict Postnatal Outcome of Renal Disease in Fetuses with Posterior Urethral Valves (PUV)Colonic catabolism of dietary phenolic and polyphenolic compounds from Concord grape juicePolyphenolic and Hydroxycinnamate Contents of Whole Coffee Fruits from China, India, and MexicoEspresso coffees, caffeine and chlorogenic acid intake: potential health implicationsIdentification of (Poly)phenolic Compounds in Concord Grape Juice and Their Metabolites in Human Plasma and Urine after Juice ConsumptionReduction of monocyte chemoattractant protein 1 and macrophage migration inhibitory factor by a polyphenol-rich extract in subjects with clustered cardiometabolic risk factorsThe Antioxidant and Chlorogenic Acid Profiles of Whole Coffee Fruits Are Influenced by the Extraction Procedures
P50
Q31148183-EA81C052-67CB-47F4-B0EA-0D01C1A19721Q34075303-5AE2E7CC-0A78-4CED-B8F8-DC686D46D0B4Q34940648-1137BF7C-77DB-46F6-8BD1-6E7A993F367FQ36942126-4FEFD9FE-7629-4676-A4F3-A80E609E7515Q38091336-199DB07E-305E-462D-A400-D279233FDE7CQ38451710-2DB3491C-9F44-4EA1-AB19-8113DB80B99EQ40628662-1766EB42-3CAC-42D0-B93A-EFBDB66DBCE1Q43131084-AFE805B1-6DD1-4B59-8D45-BB0CBD3124EFQ43205064-26EA5E86-13F4-4E01-A1FD-9B26F5B47886Q43231870-C8FEFD17-FF71-4AE5-8DD2-B6D3AF48CADBQ43235884-A78ECBA4-D453-432F-A5A5-E4762B755963Q45954933-284C0B67-2019-4546-924B-072B976A1AC5Q45965585-F7E1989B-D163-4882-AD33-C6956F09406AQ46001685-4B1DA3D9-AAFF-43CD-B928-E59F87EA9B5CQ46268198-B7079D56-230A-4165-8695-8DF6630E718FQ48582013-7ACC356B-620A-49A2-A659-D82AA202F1EEQ51014127-283585FC-74B9-47F9-877C-0757CEAAC127Q54510020-C87E7E8B-50B7-4521-9FE5-7D1532E61763Q56970450-066C37DF-B047-43D6-B255-0C2BF49A97A1Q57118032-8F16D203-E508-4678-AC1A-2ABF0B87CE2EQ57711889-AE96991C-9336-4092-949C-ADB1FE7768C0Q62981677-812AB0FA-6AE0-46E3-B3A1-079FA607E4CEQ62981713-03C9FA9F-D7C1-473A-BA84-739F22200DB3Q62981777-3E694F5E-A37B-413D-A771-C1888AD8A048Q62981797-D32E1240-8277-46C1-9FD2-D2F8819BFEF7Q62981820-AA4FFD7B-9EA3-488A-AE46-57A2B25C330DQ62981832-2CC10B47-A7F1-4E88-B385-8B85977CA588
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Angélique Stalmach
@ast
Angélique Stalmach
@en
Angélique Stalmach
@es
Angélique Stalmach
@nl
type
label
Angélique Stalmach
@ast
Angélique Stalmach
@en
Angélique Stalmach
@es
Angélique Stalmach
@nl
prefLabel
Angélique Stalmach
@ast
Angélique Stalmach
@en
Angélique Stalmach
@es
Angélique Stalmach
@nl
P1053
B-3250-2009
P106
P1153
14023613000
P21
P31
P3829
P496
0000-0003-4491-654X